Results 221 to 230 of about 2,436,106 (292)
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Characterization of Social and Repetitive Behaviors of Mllt11/Af1q/TcF7c Conditional Knockout Mice. [PDF]
Witt EA +4 more
europepmc +1 more source
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source
Action information is integrated into entorhinal representations of conceptual space and is reflected in eye movements. [PDF]
Eperon A +3 more
europepmc +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Not only gut feelings: pancreatic hormone, amylin, controls emotionality and sociability, in a sex divergent manner. [PDF]
Byun S +5 more
europepmc +1 more source
Exploring medication adherence and illness perception in patients with neuroimmune diseases: a cross-sectional study. [PDF]
Fu R, Wang X, Shi Z, Wang R, Zhou H.
europepmc +1 more source
Dual denoising contrastive learning with multi-interest fusion for sequential recommendation. [PDF]
Long H, Lu J, Dai C.
europepmc +1 more source

